Global Custom Market Research Reports Provider Company

phone

Mereo Biopharma Group Plc (MPH) - Financial and Strategic SWOT Analysis Review

  • Published Date: 13 Nov 2017
  • Number of Pages: 25
  • Category: Healthcare and Medical
  • Country: United Kingdom
Summary

Mereo Biopharma Group Plc (Mereo), formerly Mereo Biopharma Group Ltd is a provider of drug development programs. The company offers acquisition and rapid development of innovative medicines for rare and specialist disease areas. Its product pipeline comprises BPS-804 used for treating brittle bone syndrome and BCT-197, an orally active p38 MAP kinase inhibitor developed for acute exacerbations of chronic obstructive pulmonary disease. Mereo also offers BGS-649, an orally active aromatase inhibitor developed for the treatment of obese men with hypogonadotrophic hypogonadism. The company collaborates with biotechnology and pharmaceutical companies. Mereo is headquartered in London, the UK.

Mereo Biopharma Group Plc Key Recent Developments

Aug 08,2017: Mereo BioPharma: Unaudited interim results for the period ended 30 June 2017
Feb 27,2017: Mereo BioPharma Announces Preliminary results for the year ended 31 December 2016
Jan 12,2017: Mereo BioPharma: Directorate update
Jan 12,2017: Mereo BioPharma Group: Directorate update
Dec 12,2016: Mereo BioPharma Group: Business Update

This comprehensive SWOT profile of Mereo Biopharma Group Plc provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalDatas Profile on Demand service, covering over 50,000 of the worlds leading companies. Once purchased, GlobalDatas highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Mereo Biopharma Group Plc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,



- Business description A detailed description of the companys operations and business divisions.

- Corporate strategy Analysts summarization of the companys business strategy.

- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.

- Company history Progression of key events associated with the company.

- Major products and services A list of major products, services and brands of the company.

- Key competitors A list of key competitors to the company.

- Key employees A list of the key executives of the company.

- Executive biographies A brief Summary of the executives employment history.

- Key operational heads A list of personnel heading key departments/functions.

- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.



Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,



You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.



Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.



Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.



Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.



Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Publisher Name : GlobalData
Table of Contents


Section 1 - About the Company



Mereo Biopharma Group Plc - Key Information

Mereo Biopharma Group Plc - Overview

Mereo Biopharma Group Plc - Key Employees

Mereo Biopharma Group Plc - Key Employee Biographies

Mereo Biopharma Group Plc - Key Operational Heads

Mereo Biopharma Group Plc - Major Products and Services

Mereo Biopharma Group Plc - History

Mereo Biopharma Group Plc - Company Statement

Mereo Biopharma Group Plc - Locations And Subsidiaries

Mereo Biopharma Group Plc - Key Manufacturing facilities

Head Office

Other Locations & Subsidiaries



Section 2 - Company Analysis



Mereo Biopharma Group Plc - Business Description

Mereo Biopharma Group Plc - Corporate Strategy

Mereo Biopharma Group Plc - SWOT Analysis

SWOT Analysis - Overview

Mereo Biopharma Group Plc - Strengths

Mereo Biopharma Group Plc - Weaknesses

Mereo Biopharma Group Plc - Opportunities

Mereo Biopharma Group Plc - Threats

Mereo Biopharma Group Plc - Key Competitors



Section 3 - Company Financial Performance Charts



Mereo Biopharma Group Plc - Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts



Section 4 - Appendix



Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer





Note*: Some sections may be missing if data is unavailable for the company

List Of Tables




Mereo Biopharma Group Plc, Key Information

Mereo Biopharma Group Plc, Key Ratios

Mereo Biopharma Group Plc, Share Data

Mereo Biopharma Group Plc, Major Products and Services

Mereo Biopharma Group Plc, History

Mereo Biopharma Group Plc, Key Employees

Mereo Biopharma Group Plc, Key Employee Biographies

Mereo Biopharma Group Plc, Key Operational Heads

Mereo Biopharma Group Plc, Other Locations

Mereo Biopharma Group Plc, Subsidiaries

Mereo Biopharma Group Plc, Key Manufacturing facilities

Mereo Biopharma Group Plc, Key Competitors

Mereo Biopharma Group Plc, SWOT Analysis

Mereo Biopharma Group Plc, Ratios based on current share price

Mereo Biopharma Group Plc, Annual Ratios

Mereo Biopharma Group Plc, Interim Ratios

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List Of Figures




Mereo Biopharma Group Plc, Performance Chart

Mereo Biopharma Group Plc, Ratio Charts

Mereo Biopharma Group Plc (Mereo), formerly Mereo Biopharma Group Ltd is a provider of drug development programs. The company offers acquisition and rapid development of innovative medicines for rare and

View Report

Mereo Biopharma Group Plc (Mereo), formerly Mereo Biopharma Group Ltd is a provider of drug development programs. The company offers acquisition and rapid development of innovative medicines for rare and

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports